Cystic Fibrosis: A Descriptive Analysis of Deaths in a Two-Decade Period in Brazil According to Age, Race, and Sex.

Luan Victor Frota de Azevedo, Fernanda Cristine Ribeiro Medeiros Cruz, Jéssica Paula Martins, Fernando Augusto Lima Marson
Author Information
  1. Luan Victor Frota de Azevedo: Laboratory of Cell and Molecular Tumor Biology and Bioactive Compounds, Laboratory of Human and Medical Genetics, Postgraduate Program in Health Science, São Francisco University, Bragança Paulista 12916-900, Brazil.
  2. Fernanda Cristine Ribeiro Medeiros Cruz: Laboratory of Cell and Molecular Tumor Biology and Bioactive Compounds, Laboratory of Human and Medical Genetics, Postgraduate Program in Health Science, São Francisco University, Bragança Paulista 12916-900, Brazil.
  3. Jéssica Paula Martins: Laboratory of Cell and Molecular Tumor Biology and Bioactive Compounds, Laboratory of Human and Medical Genetics, Postgraduate Program in Health Science, São Francisco University, Bragança Paulista 12916-900, Brazil. ORCID
  4. Fernando Augusto Lima Marson: Laboratory of Cell and Molecular Tumor Biology and Bioactive Compounds, Laboratory of Human and Medical Genetics, Postgraduate Program in Health Science, São Francisco University, Bragança Paulista 12916-900, Brazil. ORCID

Abstract

The diagnosis of cystic fibrosis has improved in the last few years due to greater access to diagnostic tools and the evolution of molecular biology; the knowledge obtained has contributed to the understanding of its death profile. In this context, an epidemiological study was developed focusing on deaths from cystic fibrosis in Brazil from 1996 to 2019. The data were collected from the Data-SUS (Unified National Health System Information Technology Department from Brazil). The epidemiological analysis included patients' age groups, racial groups, and sex. In our data, between 1996 and 2019, Σ3050 deaths were recorded, totaling a ≅330% increase in the number of deaths resulting from cystic fibrosis. This fact might be related to a better diagnosis of the disease, mainly in patients from racial groups that are not commonly associated with cystic fibrosis, such as Black individuals, Hispanic or Latino (mixed individuals/) individuals, and American Indians (Indigenous peoples from Brazil). Regarding of race, the Σ of deaths was: nine (0.3%) in the American Indian group, 12 (0.4%) in the Asian group, 99 (3.6%) in the Black or African American group, 787 (28.6%) in the Hispanic or Latino group, and 1843 (67.0%) in the White group. The White group showed the highest prevalence of deaths, and the increase in mortality was ≅150 times in this group, while, in the Hispanic or Latino group, it was ≅75 times. Regarding sex, the numbers and percentage of deaths of both male ( = 1492; 48.9%) and female ( = 1557; 51.1%) patients were seen to be relatively close. As for age groups, the >60-year-old group presented the most significant results, with an increase of ≅60 times in the registered deaths. In conclusion, in Brazil, despite the number of deaths from cystic fibrosis being prevalent in the White group, it increased in all racial groups (Hispanic or Latino, Black or African American, American Indian, or Asian individuals) and was associated with older age.

Keywords

References

  1. Med Clin North Am. 2022 Nov;106(6):1001-1012 [PMID: 36280328]
  2. Int J Environ Res Public Health. 2022 Apr 27;19(9): [PMID: 35564707]
  3. Genes (Basel). 2020 May 26;11(6): [PMID: 32466381]
  4. J Cyst Fibros. 2016 Nov;15(6):791-793 [PMID: 27262748]
  5. J Cyst Fibros. 2022 May;21(3):456-462 [PMID: 35125294]
  6. Pediatr Pulmonol. 2019 Nov;54 Suppl 3:S74-S83 [PMID: 31715087]
  7. J Bras Pneumol. 2017 May-Jun;43(3):219-245 [PMID: 28746534]
  8. J Patient Exp. 2022 Jul 14;9:23743735221112629 [PMID: 35860790]
  9. Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1323-1331 [PMID: 30716472]
  10. J Bras Pneumol. 2020 Mar 2;46(2):e20190308 [PMID: 32130336]
  11. Genet Med. 2022 Oct;24(10):2180-2186 [PMID: 35857025]
  12. Lancet Respir Med. 2016 Aug;4(8):e37-e38 [PMID: 27377414]
  13. J Glob Health. 2022 Jul 25;12:05027 [PMID: 35871427]
  14. J Bras Pneumol. 2017 Mar-Apr;43(2):121-128 [PMID: 28538779]
  15. J Mol Diagn. 2016 Jan;18(1):39-50 [PMID: 26708955]
  16. Ann Am Thorac Soc. 2017 Jan;14(1):1-7 [PMID: 27870577]
  17. Am J Respir Crit Care Med. 2021 Jun 15;203(12):1522-1532 [PMID: 33734030]
  18. J Clin Med. 2020 Dec 23;10(1): [PMID: 33374882]
  19. J Cyst Fibros. 2021 May;20(3):473-484 [PMID: 32819855]
  20. Sci Rep. 2019 Apr 17;9(1):6234 [PMID: 30996306]
  21. Sci Rep. 2019 Jun 18;9(1):8693 [PMID: 31213628]
  22. Pediatr Pulmonol. 2018 Jul;53(7):888-900 [PMID: 29635781]
  23. J Pediatr. 2016 Aug;175:150-158.e1 [PMID: 27131402]
  24. J Cell Mol Med. 2022 Dec;26(23):5943-5947 [PMID: 36369753]
  25. Pediatr Pulmonol. 2021 Jun;56(6):1496-1503 [PMID: 33470563]
  26. Lancet Respir Med. 2020 Jan;8(1):65-124 [PMID: 31570318]
  27. Presse Med. 2017 Jun;46(6 Pt 2):e97-e108 [PMID: 28576637]
  28. Front Pharmacol. 2020 Feb 21;10:1662 [PMID: 32153386]
  29. Pulmonology. 2022 May-Jun;28(3):235-238 [PMID: 34702678]
  30. Pediatr Pulmonol. 2020 Jun;55(6):1381-1387 [PMID: 32176840]
  31. J Infect. 2022 Sep;85(3):318-321 [PMID: 35700866]
  32. AJR Am J Roentgenol. 2017 Jul;209(1):3-18 [PMID: 28639921]
  33. Am J Respir Crit Care Med. 2021 Feb 1;203(3):381-385 [PMID: 32969708]
  34. Cureus. 2021 Feb 24;13(2):e13526 [PMID: 33786233]
  35. BMC Pediatr. 2021 Mar 31;21(1):154 [PMID: 33789612]
  36. Front Pharmacol. 2017 Jun 20;8:390 [PMID: 28676762]
  37. Dis Markers. 2021 Feb 3;2021:9812074 [PMID: 33613790]
  38. Nat Rev Gastroenterol Hepatol. 2016 Mar;13(3):175-85 [PMID: 26790364]
  39. Curr Opin Pulm Med. 2018 May;24(3):296-308 [PMID: 29517584]
  40. Genes (Basel). 2022 Jul 15;13(7): [PMID: 35886035]
  41. Curr Opin Pulm Med. 2018 Nov;24(6):574-578 [PMID: 30281026]
  42. Orphanet J Rare Dis. 2022 Mar 21;17(1):129 [PMID: 35313924]
  43. Respirology. 2016 Apr;21(3):449-59 [PMID: 26677803]
  44. Clin Chest Med. 2022 Dec;43(4):579-590 [PMID: 36344067]
  45. J Med Genet. 1999 Jan;36(1):41-4 [PMID: 9950364]
  46. Respirology. 2015 Nov;20(8):1172-81 [PMID: 26437683]
  47. N Engl J Med. 2019 Nov 7;381(19):1809-1819 [PMID: 31697873]

Word Cloud

Created with Highcharts 10.0.0groupdeathscysticfibrosisBrazilgroupsAmericanHispanicLatinodiagnosisageracialincreaseBlackindividualsWhitetimesepidemiological19962019datasexnumberpatientsassociatedRegardingrace0IndianAsian6%African=screeningimprovedlastyearsduegreateraccessdiagnostictoolsevolutionmolecularbiologyknowledgeobtainedcontributedunderstandingdeathprofilecontextstudydevelopedfocusingcollectedData-SUSUnifiedNationalHealthSystemInformationTechnologyDepartmentanalysisincludedpatients'Σ3050recordedtotaling≅330%resultingfactmightrelatedbetterdiseasemainlycommonlymixedindividuals/IndiansIndigenouspeoplesΣwas:nine3%124%993787281843670%showedhighestprevalencemortality≅150≅75numberspercentagemale1492489%female1557511%seenrelativelyclose>60-year-oldpresentedsignificantresults≅60registeredconclusiondespiteprevalentincreasedolderCysticFibrosis:DescriptiveAnalysisDeathsTwo-DecadePeriodAccordingAgeRaceSexCFTRdistributionperepidemiologygenetichumandevelopmentindexneonatalsweattest

Similar Articles

Cited By